Best Posters

During the 29th Annual EAU Congress 1145 posters were presented in 92 poster sessions. During each poster session the two best posters were selected. You will find an overview of all these best posters below.

Saturday, 12 April 2014

Abstract Session No. Poster
Expression of androgen and estrogen signalling components and stem cell markers is highly predictive cancer progression of metastatic prostate cancer Session: Critical evaluation of established markers in prostate cancer Poster Session 9 109
Functional outcomes over 10 years after artificial urinary sphincter (AMS 800) implantation in men with stress urinary incontinence Session: Sphincter or sling in PPI Poster Session 6 65
Expression profile of epithelial-mesenchymal transition markers in non-muscle invasive urothelial carcinoma of the bladder: Correlation with intravesical recurrence following transurethral resection Session: Bladder cancer cell biology Poster Session 20 240
Long term follow-up of a large active surveillance cohort Session: Prostate cancer: Active surveillance Poster Session 3 26
Implications of circulating tumor cells on adjuvant chemotherapy decision-making in patients with urothelial carcinoma of the bladder treated with radical cystectomy Session: High quality cystectomy Poster Session 10 117
The evolution of urethroplasty for bulbar urethral stricture disease; more options, better outcomes Session: Urethral stricture diseases Poster Session 7 87
Polymorphisms of carcinogen transporting gene SLCO1B1 associate with bladder cancer susceptibility Session: Bladder cancer biomarkers in prediction of disease aggresiveness Poster Session 12 150
Offspring production with sperm grown in vitro from cryopreserved testis tissues Session: Male infertility: Basic to clinical Poster Session 13 154
Development of a realistic in vivo bone metastasis model for human renal cell carcinoma Session: RCC: New therapeutic approaches and drug response Poster Session 16 188
Radiologic response predict prognosis in patients with muscle invasive bladder cancer undergoing carboplatin-based neoadjuvant chemotherapy Session: Optimizing outcomes post cystectomy Poster Session 18 215
Clinical and pathological characteristics of the patients in spite of positive surgical margins who were free from biochemical recurrence after radical prostatectomy Session: Predictors for oncological outcome after radical prostatectomy Poster Session 14 173
Chemoinduced downstaging as a potential surrogate marker of efficacy and of increased survival following neoadjuvant chemotherapy of locally advanced urothelial urinary bladder cancer Session: High quality cystectomy Poster Session 10 116
Hydrogel based drug retention system for the treatment of upper tract urothelial carcinoma Session: Upper urinary tract urothelial cancer Poster Session 2 25
Cortactin-mediated invadopodia formation is essential for transurothelial invasion and extravasation during bladder cancer metastasis Session: Bladder cancer cell biology Poster Session 20 246
Does intraoperative fluid restriction combined with preemptive noepinephrine affect functional outcome in patients undergoing radical cystectomy wit orthotopic bladder substitution? Session: Whats new in urinary diversion Poster Session 15 182
The abdominal CT radiation does not modify seminal parameters Session: Male infertility: Clinical Poster Session 21 260
Epithelial markers for the molecular detection of occult lymph node metastases are here to stay Session: Critical evaluation of established markers in prostate cancer Poster Session 9 111
Combination therapy with sunitinib and 177-Lu-girentuximab in RCC Session: RCC: New therapeutic approaches and drug response Poster Session 16 192
Two-dimensional perineal ultrasonography in men before and after radical prostatectomy Session: Sphincter or sling in PPI Poster Session 6 73
Polyamide targeting transcription of long chain acyl-CoA synthetase 3: A novel therapeutic approach for prostate cancer Session: Novel approaches to overcome therapy resistance in prostate cancer Poster Session 1 2
Frequency and prognostic value of PTEN loss in patients with upper tract urothelial carcinoma Session: Upper urinary tract urothelial cancer Poster Session 2 17
Notch2 promotes bladder cancer progression: Pre-clinical rationale for a novel targeted therapy Session: Molecular diagnostic and biomarkers of bladder cancer Poster Session 4 39
Molecular classification of T1 urothelial bladder cancer identifies high-risk subtypes Session: Molecular diagnostic and biomarkers of bladder cancer Poster Session 4 40
Surgical management of benign prostatic obstruction: Current practice patterns and attitudes in Europe Session: Surgical and minimally invasive therapy in BPE, whats new? Poster Session 19 226
Neo-adjuvant and adjuvant combination of a taxane plus cisplatin and 5-fluorouracil in patients undergoing lymph-node dissection for nodal metastases from squamous cell carcinoma (SCC) of the penis: Is there an indication for a recommendable use? Session: Penile cancer Poster Session 5 57
Efficacy of an exercise-based rehabilitation programme in radical cystectomy pathways: A randomised controlled trial Session: Optimizing outcomes post cystectomy Poster Session 18 219
Analysis of renal tissue environment using quantitative proteomics techniques: Healthy tissue from donors vs healthy tissue from renal cell carcinoma kidneys Session: RCC: Molecular characterisation and prognosis markers Poster Session 24 292
Renal surgery in the elderly - validation of perioperative outcomes and postoperative complications in 160 consecutive patients undergoing retroperitoneoscopic partial nephrectomy Session: Options for preserving renal function Poster Session 8 90
Reconstruction of long ureteral defects using reinforced tubular collagen scaffolds in a preclinical animal model Session: Upper tract surgery for benign disease Poster Session 23 283
Pelvic lymph node dissection can be safely omitted in men with a risk of nodal metastases ≤5% based on the Briganti nomogram: Validation of the EAU guidelines reccommendations for nodal dissection based on patient outcome Session: Management of lymph node disease in prostate cancer Poster Session 22 266
Assessing the optimal postoperative management of node positive prostate cancer patients: Results from a large, multi-institutional series Session: Management of lymph node disease in prostate cancer Poster Session 22 262
Outcome of radical prostatectomy for misclassified active surveillance candidates Session: Prostate cancer: Active surveillance Poster Session 3 36
Atherosclerosis-associated mixed testicular atrophy: Novel hormonal and microvascular aspects in ApoE-/-/LDL receptor-/- double knockout mouse model Session: Male infertility: Basic to clinical Poster Session 13 155
When is a conservative management recommended for ureterointestinal strictures following radical cystectomy with ileal conduit? Session: Upper tract surgery for benign disease Poster Session 23 284
Country-specific, externally validated pre and post-treatment prostate cancer nomograms for the prediction of pathological stage and biochemical recurrence-free survival Session: Predictors for oncological outcome after radical prostatectomy Poster Session 14 170
PROPIL’s study, early outcomes at 1 month: Evolution of the penetration depth by enhanced contrast ultrasonography after photovaporization of the prostate by the GREENLIGHT laser XPS® Session: Lasers for BPE Poster Session 11 127
Wnt/β-catenin signalling is a potential therapeutic target for castrate-resistant prostate cancer Session: Novel approaches to overcome therapy resistance in prostate cancer Poster Session 1 3
Validation of a genomic classifier for predicting biochemical failure following post-operative radiation therapy in high-risk prostate cancer Session: Improvement in prostate cancer biomarkers measurement Poster Session 17 205
Renal scanning functional outcomes of “clampless” laparoscopic partial nephrectomy: The viable harmless alternative to “clamped”? Session: Options for preserving renal function Poster Session 8 92
Pre-clinical and clinical translation of a tissue engineered neo−urinary conduit using adipose derived smooth muscle cells for urinary reconstruction Session: Whats new in urinary diversion Poster Session 15 178
Verification of a functionalized structured medical wire for the isolation of circulating tumor cells (CTC) in patients with renal cell carcinoma Session: RCC: Molecular characterisation and prognosis markers Poster Session 24 291
Prevalence and characteristics of metabolic syndrome in Caucasian-European men presenting for primary couple’s infertility: Results of a cross-sectional survey Session: Male infertility: Clinical Poster Session 21 253
A four-gene expression signature to predict progression in high risk non-muscle invasive bladder cancer Session: Bladder cancer biomarkers in prediction of disease aggresiveness Poster Session 12 149
Feasibility of performing delayed dynamic sentinel lymph node biopsy (DSNB) following primary surgery for penile carcinoma Session: Penile cancer Poster Session 5 62
The changing practice of TURP Session: Surgical and minimally invasive therapy in BPE, whats new? Poster Session 19 236
Fine-mapping of the Kallikrein region and its role in prostate cancer aggressiveness: Results from a Canadian cohort and the European Randomized Study for Prostate Cancer Screening Session: Improvement in prostate cancer biomarkers measurement Poster Session 17 206
Urethroplasty after irradiation Session: Urethral stricture diseases Poster Session 7 80

Sunday, 13 April 2014

Abstract Session No. Poster
Dimitrij Oscarovic Ott (1855–1929): A Russian pioneer of laparoscopy and NOTES Session: History of urology Poster Session 27 337
Retractile testis presents anatomical anomalies? Study in 152 patients Session: Paediatric urology: Bladder and external genitalia Poster Session 54 668
Focal therapy in prostate cancer - international multidisciplinary consensus on trial design Session: Focal therapy for prostate cancer: New insights Poster Session 29 354
Comparison of radical treatment and mortality in patients with non-metastatic prostate cancer in England and USA Session: Oncological outcomes after radical prostatectomy Poster Session 34 415
Long-term testosterone treatment over 5 years leads to progressive weight loss and waist size reduction as well as improvement of metabolic syndrome parameters in elderly men with hypogonadism Session: Men´s sexual health: Testosterone, premature ejaculation and Peyronies disease Poster Session 58 705
Pilot study of liposome encapsulated onabotulinumtoxinA for patients with overactive bladder – clinical results and changes of urothelial sensory proteins in a single centre Session: Refractory OAB Poster Session 47 579
68Gallium-labelled ligand of prostate-specific membrane antigen (PSMA) for the evaluation of recurrent prostate cancer using PET/CT and PET/MR imaging Session: Prostate cancer clinical staging - the limits of imaging? Poster Session 59 726
Urothelial bladder cancer: Bcl-2 is upregulated in lymph node metastases and a marker of unfavourable response to neoadjuvant chemotherapy Session: Experimental therapies for bladder cancer Poster Session 33 405
Laparoendoscopic single site partial nephrectomy: A multi-institutional cumulative analysis Session: How to perform partial nephrectomy? Poster Session 35 431
Aortic calcification index (ACI) of the patients with primary aldosteronism (PA) is an independent predictor of hypertensive status at 1 year after laparoscopic adrenalectomy (LA) Session: Imaging and minimally invasive surgery in retroperitoneal tumours Poster Session 32 400
An evaluation of the predictive value of serum CA19-9 in patients with upper urinary tract urothelial carcinoma Session: Beyond conventional endoscopy Poster Session 51 631
Abulcasis (936-1013), the great surgeon of Cordova (Al-Andalus), one thousand years after Session: History of urology Poster Session 27 325
Botulinum toxin A enters normal human urothelial cells and modulates the sensory activity of bladder urothelium Session: Botulinum toxin: From bench to bedside Poster Session 57 695
Long term improvement and stability of peak flow rates across ages or in men with baseline PFR < 10 following robotic assisted radical prostatectomy (RARP) Session: Morbidity and functional outcomes of treatments for prostate cancer Poster Session 43 531
The “Vacuum cleaner effect” in minimal invasive nephrolitholapaxy (MIP) – illustration of the effect by computational fluid dynamics Session: Technical innovation in PCNL Poster Session 50 612
Radical prostatectomy: D'Amico risk groups optimization adding MRI information Session: Prostate cancer clinical staging - the limits of imaging? Poster Session 59 721
The relationship between the colon and the kidney in flank free modified supine position versus prone position on computed tomography Session: PCNL: Outcomes, safety and complexity Poster Session 41 500
Low-intensity shockwave treatment for ED - long term follow up of 2 years Session: Men´s sexual health: Treatment of erectile dysfunction Poster Session 49 603
The development and validation a new nomogram for diagnosing bladder outlet obstruction in women Session: New ideas in LUTD: Obstruction or underactivity Poster Session 56 687
MicroRNA profiling of outlet obstruction-induced bladder dysfunction Session: New ideas in LUTD: Obstruction or underactivity Poster Session 56 685
Specific pharmacokinetic aspects in levofloxacin therapy of chronic bacterial prostatitis related to prostate hemodynamics Session: Infectious prostate disease Poster Session 46 562
Knockdown of antiapoptotic Bcl-xL and survivin decreases bladder cancer cell growth and increases the efficacy of chemotherapeutics whereas antiapoptotic BCL2 and XIAP are of minor importance for bladder cancer proliferation Session: Experimental therapies for bladder cancer Poster Session 33 413
Urinary rhabdosphincter bioengineering: A decellularized urethra matrix for modelling SUI in vitro and tissue engineering applications Session: Cell based therapies for bladder and urethral dysfunction Poster Session 39 484
Prospective comparison of erectile function after radical prostatectomy and low dose brachytherapy for low-risk prostate cancer Session: Men´s sexual health: Treatment of erectile dysfunction Poster Session 49 608
Consistent long-term efficacy and safety of onabotulinumtoxinA in patients with neurogenic detrusor overactivity: Final results of repeated treatments up to 4 years Session: Botulinum toxin: From bench to bedside Poster Session 57 693
FAAH inhibition reverses bladder hyperactivity and pain induced by cystitis through a CB1 dependent mechanism Session: Shooting at new targets in bladder overactivity and underactivity Poster Session 30 372
Targeting HER2 with trastuzumab-DM1 (T-DM1) is highly effective in preclinical models of HER2-overexpressing bladder cancer Session: Novel experimental therapies and resistance in urothelial cancer Poster Session 42 522
Prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with prostatectomy Session: Prognostic biomarkers in prostate cancer Poster Session 28 344
Seven hours - rapid antimicrobial susceptibility testing in the setting of urinary tract infection by using isothermal microcalorimetry Session: Kidney and bladder infections Poster Session 55 679
Resveratrol suppresses innate immune responses following Trans-Rectal UltraSound guided (TRUS) biopsy of the prostate Session: Infectious prostate disease Poster Session 46 563
Novel prostate cancer specific transcripts identified using RNA-seq Session: miRNA and novel regulatory molecules in prostate cancer Poster Session 25 299
Laparoscopic partial adrenalectomy for aldosterone producing adenoma diagnosed by super-selective ACTH-stimulated adrenal venous sampling Session: Imaging and minimally invasive surgery in retroperitoneal tumours Poster Session 32 395
A randomized, open-label, multicentre study of efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate (HA 1.6% and CS 2%) vs dimethyl sulfoxide (DMSO 50%) in women with Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC) Session: PBS, hemorrhagic and interstitial cystitis Poster Session 38 464
Linking endothelial progenitor cells and diabetic erectile dysfunction Session: Preclinical innovation - the future of erectile dysfunction treatment? Poster Session 40 492
Expression of monoacylglycerase (MAGL) in the human lower urinary tract: A new target for intervention into the endocannabinoid system? Session: Shooting at new targets in bladder overactivity and underactivity Poster Session 30 369
Adherence to oral anticholinergics: A long-term, population-based analysis within an equal access health care system of 24.319 patients Session: Refractory OAB Poster Session 47 575
Development of the main components of erectile tissue in the human penis during the fetal period (2nd and 3rd trimesters of gestation) Session: Paediatric urology: Hypospadias and embriology Poster Session 36 444
Testosterone prior to hypospadias repair: Complication rates and long-term cosmetic results, penile length and body height Session: Paediatric urology: Hypospadias and embriology Poster Session 36 439
Nephron sparing surgery does not decrease other-causes mortality relative to radical nephrectomy in patients with clinical T1a-T1b renal mass: Results from a large multi-institutional study Session: Renal function and survival after partial nephrectomy Poster Session 53 646
The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder outlet obstruction-induced overactive bladder Session: Cell based therapies for bladder and urethral dysfunction Poster Session 39 474
Stress urinary incontinence: Monarc™ versus miniarc® Session: All about SUI and POP Poster Session 31 385
Differential metabolic effects of medium-chain triglycerides and omega-3 fatty acids in benign and malignant prostate cells – evidence for a ketogenic diet as adjuvant therapy for prostate cancer Session: miRNA and novel regulatory molecules in prostate cancer Poster Session 25 305
Phase 3 study of adjuvant radiotherapy vs wait and see after radical prostatectomy in pT3 prostate cancer (ARO 96-02 trial) – persisting PSA is a prognostic factor and correlates with worse 10-year survival Session: Oncological outcomes after radical prostatectomy Poster Session 34 423
Negative impact of reduced first undisturbed sleep period on utility, productivity and health-related quality of life: Results of a real world survey of patients in Europe and USA Session: Nocturia and nocturnal polyuria Poster Session 48 591
Extent to which a voiding diary is used to reach diagnosis in nocturia patients: Results of a real world survey of physicians and patients in Europe and the USA Session: Nocturia and nocturnal polyuria Poster Session 48 595
The effect of chondroitin sulphate on the barrier of urothelium Session: PBS, hemorrhagic and interstitial cystitis Poster Session 38 469
CYR61/CCN1 mediates HGF linked migration/invasion and promotes phenotypic aggression and poor prognosis in MIBC Session: Novel experimental therapies and resistance in urothelial cancer Poster Session 42 523
ERG-expression is an independent predictor of disease progression during active surveillance Session: Prognostic biomarkers in prostate cancer Poster Session 28 345
Radical prostatectomy vs radiotherapy among older patients with clinically advanced prostate cancer Session: Treatment of high risk prostate cancer Poster Session 52 645
Safe and optimal pneumoperitoneal pressure for transperitoneal laparoscopic renal surgery in infant less than 10 kg, looked beyond intra-operative period: A prospective and randomized study Session: Paediatric urology: Upper urinary tract Poster Session 45 548
Minimally invasive versus open pyeloplasty in children: The differential effect of procedure volume on operative outcomes Session: Paediatric urology: Upper urinary tract Poster Session 45 551
Safety of supracostal access during percutaneous nephrolithotomy Session: PCNL: Outcomes, safety and complexity Poster Session 41 507
Prognostic influence of chromophobe subtype and sarcomatoid dedifferentiation in patients with renal cell carcinoma and impact of clinical and histopathological parameters on disease-specific survival in patients with collecting duct renal cell carcinoma (CDRCC): Results of comprehensive analyses of the CORONA and SATURN databases and development of a disease-specific risk-model for CDRCC patients Session: Renal tumors: From biopsy to prognosis Poster Session 26 317
Predictors of 30-day acute renal failure following radical and partial nephrectomy Session: Renal function and survival after partial nephrectomy Poster Session 53 654
Intratunical injection of human adipose tissue–derived stem cells partially reverts fibrosis and restores collagen III/I ratio in a rat model of chronic Peyronie’s disease Session: Preclinical innovation - the future of erectile dysfunction treatment? Poster Session 40 487
Current trends in management of high-risk prostate cancer in Europe: Results of a web-based survey by the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology Session: Treatment of high risk prostate cancer Poster Session 52 640
Urodynamics useless before surgery for female stress urinary incontinence: Are you sure? Results from a multicenter single nation database Session: All about SUI and POP Poster Session 31 386
Does mutation in gyrA or parC or efflux pump expression play the main role in fluoroquinolone-resistant Escherichia coli urinary tract infections? Session: Urological infection therapy Poster Session 37 457
Predictive factors of positive surgical margins in nephron sparing surgery: A prospective multicenter comparative study (RECORd1 project) Session: Planning and techniques of partial nephrectomy Poster Session 44 538
Stool problems during potty training: Contributing factors Session: Paediatric urology: Bladder and external genitalia Poster Session 54 662
Clinical outcomes of collagenase clostridium histolyticum in the treatment of subjects with Peyronie’s disease by subgroups: Two large double-blind, randomized, placebo-controlled phase 3 studies Session: Men´s sexual health: Testosterone, premature ejaculation and Peyronies disease Poster Session 58 715
Can MRI improve selection of patients eligible for focal therapy in localized prostate cancer ? Session: Focal therapy for prostate cancer: New insights Poster Session 29 357
Endoscopic molecular imaging of human bladder cancer with anti-CD47 Session: Beyond conventional endoscopy Poster Session 51 622
Predictive factors of surgical complication, ischemia time and trifecta outcome in cT1b renal masses. Report of a multicentric international prospective study Session: Planning and techniques of partial nephrectomy Poster Session 44 540
The learning curve for robotic partial nephrectomy in a high volume robotic surgery centre Session: How to perform partial nephrectomy? Poster Session 35 435
Serum and urine biomarker profile of kidney injury after (partial) tumor nephrectomy Session: Renal tumors: From biopsy to prognosis Poster Session 26 323
Is the striated urethral sphincter at risk by standard suture ligation of the dorsal vein complex in radical prostatectomy? An anatomical study in adult human male cadavers Session: Morbidity and functional outcomes of treatments for prostate cancer Poster Session 43 533
Static versus dynamic anatomy of the collecting system during ECIRS (Endoscopic Combined IntraRenal Surgery): Contribution of a fusion imaging technique and of the preliminary retrograde flexible ureteroscopy Session: Technical innovation in PCNL Poster Session 50 610
Appropriate prophylactic antibiotic use for patients to undergo urological surgery reduces direct and indirect costs Session: Urological infection therapy Poster Session 37 459
Antibiotic prophylaxis for flexible cystoscopy: A systematic review and meta-analysis Session: Kidney and bladder infections Poster Session 55 680

Monday, 14 April 2014

Abstract Session No. Poster
The impact of robotic-assisted radical prostatectomy on pelvic lymph node dissection and perioperative outcomes in patients with high-risk prostate cancer Session: Technical aspects of robot-assisted prostatectomy Poster Session 78 967
Mutual regulation between Raf/MEK/ERK signalling and Y-box-binding protein-1 promotes prostate cancer progression Session: Signaling pathways in prostate tumor and stem cells Poster Session 68 843
Expression of molecular markers associated with the mammalian target of rapamycin pathway in non-metastatic renal cell carcinoma: Impact on prognostic outcomes following radical nephrectomy Session: Novel views on the management of renal tumors Poster Session 92 1138
A randomized phase 2 study evaluating the optimal sequencing of sipuleucel-T and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC): Immune results with a focus on humoral responses Session: Androgen deprivation therapy, still work to be done Poster Session 79 980
Looking for solutions to the kidneys shortage: Xeno-transplantation of metanephroi Session: Kidney transplant: From lab to clinic Poster Session 74 908
Nadir testosterone on ADT predicts for time to castrate resistant progression: A secondary analysis of the PR-7 intermittent vs continuous ADT trial Session: Androgen deprivation therapy, still work to be done Poster Session 79 973
Reactive stromal grading predicts prostate cancer-specific death in a conservatively managed needle biopsy cohort Session: Diagnostic prostate biopsies Poster Session 60 740
Nomogram for prostate cancer risk in men with a previous diagnosis of prostatic intraepithelial neoplasia (PIN) Session: Diagnostic prostate biopsies Poster Session 60 735
Categories of response to first line VEGF receptor targeted therapy and overall survival in patients with metastatic renal cell carcinoma Session: Novel views on the management of renal tumors Poster Session 92 1140
Kidney volume as a predictor of 1-year renal graft function in living donor transplantation Session: Kidney transplant: From lab to clinic Poster Session 74 915
Pay attention to autonomic dysreflexia in patients with spinal cord injury during urodynamic investigation! Session: Neurogenic bladder: Diagnosis and treatment Poster Session 62 760
Predictors of survival after surgery for isolated local renal cell carcinoma recurrence Session: RCC: Prognostic factors Poster Session 84 1038
Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects outcome of patients with muscle-invasive tumors Session: Novel approaches to treatment, prognosis and prediction of response Poster Session 64 790
A randomized, double blind, placebo controlled phase II trial to evaluate the safety and efficacy of recMAGE-A3 + AS15 antigen specific cancer immunotherapy in patients with MAGE-A3 positive muscle invasive bladder cancer after cystectomy: An initial report of the EAU Research Foundation randomized phase II clinical trial ‘Magnolia’ Session: Novel approaches to treatment, prognosis and prediction of response Poster Session 64 786
Serum levels of microRNAs miR 371-3: A novel biomarker of germ cell tumours Session: Testicular tumors Poster Session 90 1111
A prospective comparison of transrectal ultrasound biopsy with an MRI based diagnostic strategy in men with suspicion of prostate cancer Session: MRI staging of prostate cancer - is it already standard? Poster Session 77 947
15-year outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma (NMIBC) treated with 5 weekly mitomycin C (MMC) instillations followed by monthly Bacillus-Calmette Guerin (BCG) or alternating BCG and interferon-α2b (IFN) instillations Session: Outcomes in non-muscle invasive bladder cancer Poster Session 89 1107
Stone volume is better than stone diameter or stone surface for predicting medical expulsion therapy success Session: Basic research related to stone treatment Poster Session 65 799
Variation of the microbial spectrum of the urine in cases of extracorporeal shock wave lithotripsy of renal pelvic stones: Preliminary results Session: Exploring the limits of ESWL Poster Session 66 819
Three novel susceptibility loci identified from a genome-wide association study (GWAS) are associated with urolithiasis risk Session: Basic research related to stone treatment Poster Session 65 805
Accuracy of index tumour mapping by real-time 3D-TRUS-based tracking of prostate targeted biopsy trajectory using elastic MR-image-fusion: A two centre study Session: Prostate cancer: Improving biopsies for screening Poster Session 67 831
Uncontrolled donation after circulatory death with Maastricht type I donors. Our experience Session: Kidney transplant surgery Poster Session 82 1013
Association of male pattern baldness and risk of cancer and high grade disease among men presenting for prostate biopsy Session: Prostate cancer: Improving biopsies for screening Poster Session 67 827
Lower pole anatomy applied to flexible ureteroscopy: Experimental study using human tridimensional endocasts Session: URS in renal stones, stents Poster Session 75 925
Recurrence prevention by combination of photodynamic diagnosis-assisted transurethral resection of the bladder and single postoperative intravesical chemotherapy instillation in patients with nonmuscle-invasive bladder cancer Session: Management strategies in non muscle invasive bladder cancer: From first diagnosis to recurrence Poster Session 81 1003
Relationship between nocturnal bladder capacity and nocturia in BPH/OAB patients with alpha1-blocker and anticholinergic treatment: Post-hoc analysis of addition study Session: BPE: Aetiology, epidemiology and treatment outcomes Poster Session 88 1091
Evaluating the accuracy of computed tomography of the kidneys, ureters and bladder interpretation by urology residents for suspected acute nephrolithasis Session: Education and training Poster Session 71 882
The surgical learning curve for an open versus laparoscopic surgeon performing robotic assisted laparoscopic prostatectomy (RALP): A single institution experience Session: Technical aspects of robot-assisted prostatectomy Poster Session 78 966
Benefit of three-dimensional printing in robotic laparoscopic renal surgery: Tangible surgical navigation using a patient-based three-dimensional printed kidney Session: New technologies and techniques Poster Session 91 1124
Development and internal validation of a preoperative nomogram for predicting the outcome of flexible ureteroscopy for the treatment of renal stone Session: URS in renal stones, stents Poster Session 75 926
The adherence to the BPH/LUTS medical therapy is low and influences the major clinical outcomes: Results from an Italian observational study Session: Towards optimization of LUTS medical treatment Poster Session 63 773
When to perform pressure flow study in patients with lower urinary tract symptoms and benign prostatic enlargement: External validation of a novel clinical nomogram Session: How to diagnose male LUTS and BPE? Poster Session 80 991
Finasteride resistance in BPH:Implications of methylated CpG island in 5-AR2 promoter and reduced 5-AR2 levels in adult prostate tissue Session: BPE: What's new in basic research? Poster Session 72 887
Prospective randomized multicenter study comparing limited vs extended pelvic lymphadenectomy in intermediate and high risk prostate cancer – first descriptive results (SEAL, AUO AP 55/09) Session: Radical prostatectomy for clinically localized prostate cancer Poster Session 61 747
Sub-stage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer Session: Modern staging of urothelial carcinomas of the bladder and the upper tract: A new era has started Poster Session 73 900
Comparison of overall survival between the life expectancy and the estimated outcome in patients who underwent radical nephrectomy for renal cell carcinoma Session: RCC: Prognostic factors Poster Session 84 1046
Impact of surgical experience on stone-free rates of ureteroscopy for single urinary calculi: A matched-paired analysis of 600 patients Session: Ureteral stones, URS in children and UTI Poster Session 83 1026
Multiparametric MRI-TRUS fusion targeted prostate biopsies: Characteristics of MRI-undetected tumour foci Session: MRI staging of prostate cancer - is it already standard? Poster Session 77 955
Impact of surgical volume on the rates of pelvic lymph node dissection in patients with prostate cancer treated with robot-assisted radical prostatectomy: Results from a tertiary referral centre Session: Surgical outcomes after open and minimally invasive radical prostatectomy Poster Session 86 1068
Prostate HistoScanning™: Does it have any role in routine clinical practice? Session: Initial prostate cancer staging - ultrasound versus MRI Poster Session 85 1048
A phase 2 trial of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-treated metastatic castration-resistant prostate cancer (MCRPC) Session: Modern management of castration-resistant prostate cancer Poster Session 70 870
Minimal invasive prostatectomy does not improve urinary continence compared to open surgery in a population based study Session: Surgical outcomes after open and minimally invasive radical prostatectomy Poster Session 86 1074
A systematic review and meta-analysis on the ejaculatory dysfunction after medical treatment for BPH: Data from 30 thousand patients enrolled in 23 RCTs Session: BPE: Aetiology, epidemiology and treatment outcomes Poster Session 88 1086
The Rho-kinase pathway is involved in fibrotic bladder hypertrophy and ureter dysfunction in a rat model of partial urethral obstruction Session: BPE: What's new in basic research? Poster Session 72 893
Prostate cancer localization by contrast-ultrasound-dispersion imaging: Results from a pilot study Session: Initial prostate cancer staging - ultrasound versus MRI Poster Session 85 1054
Radiation exposure of the patient submitted to ureteroscopy for ureteral calculi: The impact of the different factors Session: Ureteral stones, URS in children and UTI Poster Session 83 1027
Self-expanding metallic ureteral stents and extra-anatomic bypasses. Are they really effective for resolution of complex ureteral obstruction in the long-term? Session: New technologies for urology surgery Poster Session 87 1084
The role of functional polymorphism in immune response genes as biomarkers of BCG immunotherapy outcome in bladder cancer: Establishment of a predictive profile Session: Management strategies in non muscle invasive bladder cancer: From first diagnosis to recurrence Poster Session 81 1002
The impact of resident involvement in minimally invasive urologic oncology procedures Session: Education and training Poster Session 71 876
Development of bladder outlet obstruction nomogram and split-sample validation among men with LUTS aged 50 or more Session: How to diagnose male LUTS and BPE? Poster Session 80 989
Application of preoperative renal artery embolization in patients with renal cell carcinoma and venous tumor thrombus: An effective preoperative adjuvant therapy for patients with advanced tumor thrombus Session: RCC: Non-organ sparing surgery Poster Session 76 938
Discovery and validation of a novel expression signature for predicting recurrence in high-risk bladder cancer post-cystectomy Session: Modern staging of urothelial carcinomas of the bladder and the upper tract: A new era has started Poster Session 73 898
Should patients with low IPSS scores be offered pharmacological treatment? Session: Towards optimization of LUTS medical treatment Poster Session 63 783
Prognostic factors for high-grade T1 bladder cancer: A meta-analysis based on 7,486 patients Session: Outcomes in non-muscle invasive bladder cancer Poster Session 89 1101
Hes6 drives a critical androgen receptor (AR) transcriptional program to induce castration resistant prostate cancer (CRPC) through activation of an E2F1-mediated cell cycle network Session: Signaling pathways in prostate tumor and stem cells Poster Session 68 836
18-year follow-up from the Gothenburg randomised prostate cancer screening trial Session: Prostate cancer: Population-based screening Poster Session 69 848
Catheter designs, techniques and strategies for intermittent catheterisation: What is the evidence for preventing symptomatic UTI and other complications? A Cochrane systematic review Session: Neurogenic bladder: Diagnosis and treatment Poster Session 62 762
Does extracorporeal shock wave lithotripsy cause diabetes mellitus? A nation wide population based and with an 8 year follow-up study Session: Exploring the limits of ESWL Poster Session 66 815
MRI-guided transurethral ultrasound ablation of prostate cancer: Preliminary outcomes of a phase I clinical trial Session: New technologies and techniques Poster Session 91 1133
Multi-institutional validation of the ERUS robotic surgery training curriculum Session: Radical prostatectomy for clinically localized prostate cancer Poster Session 61 751
Diagnose and treatment for clinically localized prostate cancer. Adherence to EAU guidelines on prostate cancer in a nationwide population-based study Session: Prostate cancer: Population-based screening Poster Session 69 854
Total number of positive nodes and positive node ratio may predict recurrence in early stage non-seminomatous germ-cell tumours (NSGCT) undergoing primary retroperitoneal lymph-node dissection (RPLND) Session: Testicular tumors Poster Session 90 1119
Robotic kidney transplantation with regional hypothermia: Evolution of a novel procedure utilizing the IDEAL guidelines (IDEAL Phase 0 and 1) Session: Kidney transplant surgery Poster Session 82 1019
Incidence of urinary tract obstructions due to prostate cancer progression differs according to primary treatments Session: Modern management of castration-resistant prostate cancer Poster Session 70 868
Perioperative outcome and oncological follow up in a large series of patients with renal cell carcinoma invading supradiaphragmatic vena cava and treated with nephrectomy and caval thrombectomy with extracorporeal circulation and deep hypothermic circulatory arrest Session: RCC: Non-organ sparing surgery Poster Session 76 942
IPad guided puncture of the kidney - evaluation with an ex vivo model Session: New technologies for urology surgery Poster Session 87 1075